Show Notes
Part 1 of 4 of our series with Nicole Paulk, founder, CEO, and president of SIREN Biotechnology.
In this episode of The Biotech Startups Podcast, we sit down with Nicole Paulk, founder, CEO, and president of SIREN Biotechnology, a company pioneering universal AAV immunogene therapy to fight solid tumor cancers. Nicole takes us back to her roots — a scrappy, off-the-grid upbringing in the Pacific Northwest where a lumberjack dad raised her like a son and sports were everything, until recurring shoulder injuries ended her collegiate volleyball career at 18 and triggered her first identity crisis. She walks us through the hustle that followed; swim lessons, kickboxing classes, deli shifts, and crabbing in Puget Sound just to survive, and how she stumbled into science not out of passion, but out of a need for a paycheck at a small ag school. A summer treating patients in Kenya and Tanzania convinced her that clinical medicine wasn't her path, and one offhand comment from her chemistry professor set the entire trajectory of her scientific career in motion.
Key topics covered:
- Farm Kid to Founder: Growing up off-the-grid in the Pacific Northwest forged the grit and competitiveness Nicole brings to every aspect of her life and leadership
- Identity Crisis at 18: How recurring shoulder injuries ended her collegiate volleyball career and forced a complete rethinking of who she was
- Hustling Through College: Swim lessons, kickboxing classes, deli shifts, and crabbing just to make rent and stay enrolled
- Summer in Africa: Three and a half months treating patients in Kenya and Tanzania revealed she wasn't cut out for clinical medicine
- A Career-Defining Pivot: One offhand suggestion from her chemistry professor, Dr. Anya Johansen, redirected Nicole from med school to a PhD in virology
Resources & Articles
- What Is AAV Gene Therapy?: https://www.askbio.com/aav-gene-therapy/
- Ebola & Marburg Hemorrhagic Fever Viruses: https://www.cfsph.iastate.edu/Factsheets/pdfs/viral_hemorrhagic_fever_filovirus.pdf
- AAV Capsids That Evade Neutralizing Antibodies: https://www.cgtlive.com/view/maura-aav-capsids-evade-neutralizing-antibodies
- AAV as a Vector for Gene Therapy (PMC): https://pmc.ncbi.nlm.nih.gov/articles/PMC5548848/
- Volunteer Medical Work in Africa: https://idi.mak.ac.ug/opportunities/main/volunteer/
Organizations & People
- Western Washington University: https://www.wwu.edu
- Central Washington University: https://www.cwu.edu
- University of Washington: https://www.washington.edu
- Oregon Health & Science University (OHSU): https://www.ohsu.edu
- UCSF Department of Biochemistry & Biophysics: https://biophysics.ucsf.edu
- Stanford Division of Human Gene Therapy: https://med.stanford.edu/genetherapy.html
- Bill & Melinda Gates Foundation: https://www.gatesfoundation.org




